Sclerotinia-inducible genes and promoters and their uses
AssigneePioneer Hi-Bred International, Inc.
InventorsZhongmeng Bao, Guihua Lu
Life of this patent
Estimating the term…
Abstract
Compositions and methods to aid in protecting plants from invading pathogenic organisms are provided. The compositions of the invention comprise anti-pathogenic genes, including their promoters, and proteins encoded by the anti-pathogenic genes. The compositions find use in methods for reducing or eliminating damage to plants caused by plant pathogens. Transformed plants, plant cells, tissues, and seed are also provided having enhanced disease resistance.
Claims34
An isolated nucleic acid molecule having a nucleotide sequence for a promoter that is capable of initiating transcription in a plant cell, wherein said nucleotide sequence for said promoter is selected from the group consisting of:
- a) a nucleotide sequence comprising the sequence set forth in SEQ ID NO:5 or SEQ ID NO:6;
- b) a nucleotide sequence selected from the group consisting of the sequences deposited as Patent Deposit No. PTA-2182;
- c) a nucleotide sequence comprising at least 30 contiguous nucleotides of the sequence set forth in SEQ ID NO:5 or SEQ ID NO:6;
- d) a nucleotide sequence having at least 70% sequence identity to the nucleotide sequence set forth in SEQ ID NO:5 or SEQ ID NO:6;
- e) a nucleotide sequence having at least 80% sequence identity to the nucleotide sequence set forth in SEQ ID NO:5 or SEQ ID NO:6;
- f) a nucleotide sequence having at least 90% sequence identity to the nucleotide sequence set forth in SEQ ID NO:5 or SEQ ID NO:6;
- and
- g) a nucleotide sequence that hybridizes under stringent conditions to the complement of a sequence of a), b), or c).
A plant stably transformed with a DNA construct comprising a heterologous nucleotide sequence operably linked to a promoter that is capable of initiating transcription in a plant cell, wherein said promoter comprises a nucleotide sequence selected from the group consisting of:
- a) a nucleotide sequence comprising the sequence set forth in SEQ ID NO:5 or SEQ ID NO:6;
- b) a nucleotide sequence selected from the group consisting of the sequences deposited as Patent Deposit No. PTA-2182;
- c) a nucleotide sequence comprising at least 30 contiguous nucleotides of the sequence set forth in SEQ ID NO:5 or SEQ ID NO:6;
- d) a nucleotide sequence having at least 70% sequence identity to the nucleotide sequence set forth in SEQ ID NO:5 or SEQ ID NO:6;
- e) a nucleotide sequence having at least 80% sequence identity to the nucleotide sequence set forth in SEQ ID NO:5 or SEQ ID NO:6;
- f) a nucleotide sequence having at least 90% sequence identity to the nucleotide sequence set forth in SEQ ID NO:5 or SEQ ID NO:6;
- and
- g) a nucleotide sequence that hybridizes under stringent conditions to the complement of a sequence of a), b), or c).
An isolated nucleic acid molecule having a nucleotide sequence selected from the group consisting of:
- a) the sequence set forth in SEQ ID NO:1 or SEQ ID NO:3;
- b) a nucleotide sequence selected from the group consisting of the sequences deposited as Patent Deposit No. PTA-2182;
- c) a nucleotide sequence encoding the amino acid sequence set forth in SEQ ID NO:2 or SEQ ID NO:4;
- d) a nucleotide sequence encoding the amino acid sequence encoded by a nucleotide sequence deposited as Patent Deposit No. PTA-2182;
- e) a nucleotide sequence comprising at least 16 contiguous nucleotides of a nucleotide sequence of a), b), c), or d);
- f) a nucleotide sequence having at least 70% identity with SEQ ID NO:1, wherein said nucleotide sequence encodes a polypeptide having chitinase activity;
- g) a nucleotide sequence having at least 80% identity with SEQ ID NO:1, wherein said nucleotide sequence encodes a polypeptide having chitinase activity;
- h) a nucleotide sequence having at least 90% identity with SEQ ID NO:1, wherein said nucleotide sequence encodes a polypeptide having chitinase activity;
- i) a nucleotide sequence having at least 70% identity with SEQ ID NO:3, wherein said nucleotide sequence encodes a polypeptide having lipid transfer activity;
- j) a nucleotide sequence having at least 80% identity with SEQ ID NO:3, wherein said nucleotide sequence encodes a polypeptide having lipid transfer activity;
- k) a nucleotide sequence having at least 90% identity with SEQ ID NO:3, wherein said nucleotide sequence encodes a polypeptide having lipid transfer activity;
- l) a nucleotide sequence that hybridizes under stringent conditions to the complement of a sequence of a), b), c), d), or e);
- and
- m) the complement of a nucleotide sequence of a), b), c), d), e), f), g), h), i), j), k), or 1).
A plant stably transformed with a DNA construct comprising a nucleotide sequence operably linked to a promoter that drives expression of a coding sequence in a plant cell, wherein said nucleotide sequence is selected from the group consisting of:
- a) the sequence set forth in SEQ ID NO:1 or SEQ ID NO:3;
- b) a nucleotide sequence selected from the group consisting of the sequences deposited as Patent Deposit No. PTA-2182;
- c) a nucleotide sequence encoding the amino acid sequence set forth in SEQ ID NO:2 or SEQ ID NO:4;
- d) a nucleotide sequence encoding the amino acid sequence encoded by a nucleotide sequence deposited as Patent Deposit No. PTA-2182;
- e) a nucleotide sequence comprising at least 16 contiguous nucleotides of a nucleotide sequence of a), b), c), or d);
- f) a nucleotide sequence having at least 70% identity with SEQ ID NO:1, wherein said nucleotide sequence encodes a polypeptide having chitinase activity;
- g) a nucleotide sequence having at least 80% identity with SEQ ID NO:1, wherein said nucleotide sequence encodes a polypeptide having chitinase activity;
- h) a nucleotide sequence having at least 90% identity with SEQ ID NO:1, wherein said nucleotide sequence encodes a polypeptide having chitinase activity;
- i) a nucleotide sequence having at least 70% identity with SEQ ID NO:3, wherein said nucleotide sequence encodes a polypeptide having lipid transfer activity;
- j) a nucleotide sequence having at least 80% identity with SEQ ID NO:3, wherein said nucleotide sequence encodes a polypeptide having lipid transfer activity;
- k) a nucleotide sequence having at least 90% identity with SEQ ID NO:3, wherein said nucleotide sequence encodes a polypeptide having lipid transfer activity;
- l) a nucleotide sequence that hybridizes under stringent conditions to the complement of a sequence of a), b), c), d), or e);
- and
- m) the complement of a nucleotide sequence of a), b), c), d), e), f), g), h), i), j), k), or 1).
A substantially purified protein having an amino acid sequence selected from the group consisting of:
- a) the amino acid sequence set forth in SEQ ID NO:2 or SEQ ID NO:4;
- b) an amino acid sequence encoded by the nucleotide sequence deposited as Patent Deposit No. PTA-2182;
- c) an amino acid sequence that shares at least 70% sequence identity to the amino acid sequence set forth in SEQ ID NO:2, wherein said amino acid sequence has chitinase activity;
- d) an amino acid sequence that shares at least 70% sequence identity to the amino acid sequence set forth in SEQ ID NO:4, wherein said amino acid sequence has lipid transfer activity;
- e) an amino acid sequence encoded by the nucleotide sequence set forth in SEQ ID NO:1 or SEQ ID NO:3;
- and
- f) an amino acid sequence encoded by a nucleotide sequence that hybridizes under stringent conditions to the nucleotide sequence set forth in SEQ ID NO:1, wherein said amino acid sequence has chitinase activity;
- and
- g) an amino acid sequence encoded by a nucleotide sequence that hybridizes under stringent conditions to the nucleotide sequence set forth in SEQ ID NO:3, wherein said amino acid sequence has lipid transfer activity.
Dependencies are inferred from the claim text.